Crystal structure of the GLP-1 receptor bound to a peptide agonist

被引:143
作者
Jazayeri, Ali [1 ]
Rappas, Mathieu [1 ]
Brown, Alastair J. H. [1 ]
Kean, James [1 ]
Errey, James C. [1 ]
Robertson, Nathan J. [1 ]
Fiez-Vandal, Cedric [1 ]
Andrews, Stephen P. [1 ]
Congreve, Miles [1 ]
Bortolato, Andrea [1 ]
Mason, Jonathan S. [1 ]
Baig, Asma H. [1 ]
Teobald, Iryna [1 ]
Dore, Andrew S. [1 ]
Weir, Malcolm [1 ]
Cooke, Robert M. [1 ]
Marshall, Fiona H. [1 ]
机构
[1] Heptares Therapeut Ltd, BioPk,Broadwater Rd, Welwyn Garden City AL7 3AX, Herts, England
关键词
GLUCAGON-LIKE PEPTIDE-1; LIGAND-BINDING; DEGRADATION; REFINEMENT; ACTIVATION; RESIDUES; FEATURES; FAMILY; DOMAIN;
D O I
10.1038/nature22800
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Glucagon-like peptide 1 (GLP-1) regulates glucose homeostasis through the control of insulin release from the pancreas. GLP-1 peptide agonists are efficacious drugs for the treatment of diabetes. To gain insight into the molecular mechanism of action of GLP-1 peptides, here we report the crystal structure of the full-length GLP-1 receptor bound to a truncated peptide agonist. The peptide agonist retains an a-helical conformation as it sits deep within the receptor-binding pocket. The arrangement of the transmembrane helices reveals hallmarks of an active conformation similar to that observed in class A receptors. Guided by this structural information, we design peptide agonists with potent in vivo activity in a mouse model of diabetes.
引用
收藏
页码:254 / +
页数:17
相关论文
共 47 条
[1]   PHENIX: a comprehensive Python']Python-based system for macromolecular structure solution [J].
Adams, Paul D. ;
Afonine, Pavel V. ;
Bunkoczi, Gabor ;
Chen, Vincent B. ;
Davis, Ian W. ;
Echols, Nathaniel ;
Headd, Jeffrey J. ;
Hung, Li-Wei ;
Kapral, Gary J. ;
Grosse-Kunstleve, Ralf W. ;
McCoy, Airlie J. ;
Moriarty, Nigel W. ;
Oeffner, Robert ;
Read, Randy J. ;
Richardson, David C. ;
Richardson, Jane S. ;
Terwilliger, Thomas C. ;
Zwart, Peter H. .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2010, 66 :213-221
[2]  
Burnley B. Tom, 2012, ELIFE, V2012, P1
[3]   Glucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndrome [J].
Chatterjee, Sanjay ;
Ghosal, Samit ;
Chatterjee, Saurav .
WORLD JOURNAL OF DIABETES, 2016, 7 (18) :441-448
[4]   MolProbity: all-atom structure validation for macromolecular crystallography [J].
Chen, Vincent B. ;
Arendall, W. Bryan, III ;
Headd, Jeffrey J. ;
Keedy, Daniel A. ;
Immormino, Robert M. ;
Kapral, Gary J. ;
Murray, Laura W. ;
Richardson, Jane S. ;
Richardson, David C. .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2010, 66 :12-21
[5]   Residues within the Transmembrane Domain of the Glucagon-Like Peptide-1 Receptor Involved in Ligand Binding and Receptor Activation: Modelling the Ligand-Bound Receptor [J].
Coopman, K. ;
Wallis, R. ;
Robb, G. ;
Brown, A. J. H. ;
Wilkinson, G. F. ;
Timms, D. ;
Willars, G. B. .
MOLECULAR ENDOCRINOLOGY, 2011, 25 (10) :1804-1818
[6]   Met-204 and Tyr-205 are together important for binding GLP-1 receptor agonists but not their N-terminally truncated analogues [J].
de Maturana, RL ;
Treece-Birch, J ;
Abidi, F ;
Findlay, JBC ;
Donnelly, D .
PROTEIN AND PEPTIDE LETTERS, 2004, 11 (01) :15-22
[7]  
DEACON CF, 1995, J CLIN ENDOCR METAB, V80, P952, DOI 10.1210/jcem.80.3.7883856
[8]   Structural insights into agonist-induced activation of G-protein-coupled receptors [J].
Deupi, Xavier ;
Standfuss, Joerg .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2011, 21 (04) :541-551
[9]   Better models by discarding data? [J].
Diederichs, K. ;
Karplus, P. A. .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2013, 69 :1215-1222
[10]   The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling [J].
Dods, Rachel L. ;
Donnelly, Dan .
BIOSCIENCE REPORTS, 2016, 36